SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-20-035037
Filing Date
2020-11-04
Accepted
2020-11-04 16:51:36
Documents
7
Period of Report
2020-12-16
Effectiveness Date
2020-11-04

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea129325-def14a_cormedix.htm DEF 14A 320353
2 GRAPHIC img_001.jpg GRAPHIC 214240
3 GRAPHIC img_002.jpg GRAPHIC 152000
4 GRAPHIC img_003.jpg GRAPHIC 119468
5 GRAPHIC img_004.jpg GRAPHIC 202612
6 GRAPHIC img_005.jpg GRAPHIC 51602
7 GRAPHIC img_006.jpg GRAPHIC 13672
  Complete submission text file 0001213900-20-035037.txt   1259765
Mailing Address 400 CONNELL DRIVE SUITE 5000 BERKELEY HEIGHTS NJ 07922
Business Address 400 CONNELL DRIVE SUITE 5000 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34673 | Film No.: 201287359
SIC: 2834 Pharmaceutical Preparations